Erlonat (Erlotinib) is a Kinase inhibitor which is primarily used to treat cell lung cancer, or pancreatic cancer when combined with a certain other medicine. It works by inhibiting growth to adjacent tissues in the body so that the cancerous cells slow down, allowing the patient a better environment to recover and fight the cancer naturally.
Erlonat contains erlotinib and belongs to a class of medications called kinase inhibitors.
Erlonat is used for the treatment of non-small cell lung cancer. Erlonat is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body.
Manufactured By : NATCO